Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US5679683A · kind A · utility
76Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 1994 |
| Grant date | Oct 21, 1997 |
| Priority date | — |
| Expiry date | Dec 23, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 4-substituted amino benzothieno3,2-d!pyrimidine and 4-substituted amino2,3-d!pyrimidine inhibitors of epidermal growth factor receptor family of tyrosine kinases are described, as well as pharmaceutical compositions of the same, which are useful in treating proliferative diseases such as cancer, synovial pannus invasion in arthritis, psoriasis, vascular restenosis and angiogenesis and additionally useful in the treatment of pancreatitis and kidney disease as well as a contraceptive agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.